The impact of paced QRS duration on the expression of genes related to contractile function of the left ventricle in chronically paced patients from the right ventricular apex

Hellenic Journal of Cardiology - Tập 61 - Trang 274-278 - 2020
Εmmanuel Simantirakis1, Eva Arkolaki1, Joanna Kontaraki2, Gregory Chlouverakis3, Hercules Mavrakis1, Eleutherios Kallergis1, Fragiskos Parthenakis1, Panos Vardas1
1University Hospital of Heraklion, Department of Cardiology, Stavrakia, Heraklion, Greece
2University of Crete, Medical School, Genetics Department, Stavrakia, Heraklion, Greece
3University of Crete, Medical School, Department of Statistics, Stavrakia, Heraklion, Greece

Tài liệu tham khảo

Zhang, 2008, New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function, J Cardiovasc Electrophysiol, 19, 136, 10.1111/j.1540-8167.2007.01014.x Sweeney, 2003, Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction, Circulation, 107, 2932, 10.1161/01.CIR.0000072769.17295.B1 Siu, 2008, Analysis of ventricular performance as a function of pacing site and mode, Prog Cardiovasc Dis, 51, 171, 10.1016/j.pcad.2008.01.001 Kontaraki, 2010, Myocardial gene expression alterations in peripheral blood mononuclear cells of patients with idiopathic dilated cardiomyopathy, Eur J Heart Fail, 12, 541, 10.1093/eurjhf/hfq057 Arkolaki, 2015, Alterations in the expression of genes related to contractile function and hypertrophy of the left ventricle in chronically paced patients from the right ventricular apex, Europace, 17, 1563, 10.1093/europace/euv071 Rajabi, 2007, Return to the fetal gene program protects the stressed heart: a strong hypothesis, Heart Fail Rev, 12, 331, 10.1007/s10741-007-9034-1 Taegtmeyer, 2010, Return to the fetal gene program: a suggested metabolic link to gene expression in the heart, Ann N Y Acad Sci, 1188, 191, 10.1111/j.1749-6632.2009.05100.x Periasamy, 2008, Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology, Cardiovasc Res, 77, 265, 10.1093/cvr/cvm056 Shareef, 2014, Cardiac SERCA2A/B: Therapeutic targets for heart failure, Eur J Pharmacol, 724C, 1, 10.1016/j.ejphar.2013.12.018 Hayward, 2015, The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective, Hum Gene Ther, 26, 293, 10.1089/hum.2015.018 Lowes, 2002, Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents, N Engl J Med, 346, 1357, 10.1056/NEJMoa012630 Vanderheyden, 2008, Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders, J Am Coll Cardiol, 51, 129, 10.1016/j.jacc.2007.07.087 Toff, 2005, Single-chamber versus dual-chamber pacing for high-grade atrioventricular block, N Engl J Med, 353, 145, 10.1056/NEJMoa042283 Wilkoff, 2002, Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial, J Am Med Assoc, 288, 3115, 10.1001/jama.288.24.3115 Steinberg, 2005, The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II, J Cardiovasc Electrophysiol, 16, 359, 10.1046/j.1540-8167.2005.50038.x Khurshid, 2016, Longer Paced QRS Duration is Associated With Increased Prevalence of Right Ventricular Pacing-Induced Cardiomyopathy, J Cardiovasc Electrophysiol, 27, 1174, 10.1111/jce.13045 Moss, 2009, MADIT-CRT Trial Investigators: Cardiac-resynchronization therapy for the prevention of heart-failure events, N Engl J Med, 361, 1329, 10.1056/NEJMoa0906431 Deyell, 2012, Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations, Heart Rhythm, 9, 1465, 10.1016/j.hrthm.2012.05.019 Brignole, 2013, Europace, 15, 1070, 10.1093/europace/eut206 Tsiachris, 2016, Conventional pacing system:It cannot be done better, it can only change, Hellenic J Cardiol HJC, 57, 107, 10.1016/j.hjc.2016.04.003 Fanourgiakis, 2016, Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication:A prospective Single-Center Two Year Survey, Hellenic J Cardiol HJC, 57, 33, 10.1016/S1109-9666(16)30016-1 Poulidakis, 2018, Echocardiography for the management of patients with biventricular pacing: Possible roles in cardiac resynchronization therapy implementation, Hellenic J Cardiol HJC, 59, 306, 10.1016/j.hjc.2018.02.006 Sideris, 2017, Leadless Pacing System: Initial experience with a novel technology in Greece, Hellenic J Cardiol HJC, 58, 461, 10.1016/j.hjc.2017.06.003 Aziz, 2007, Peripheral blood gene expression profiling for cardiovascular disease assessment, Genomic Medicine, 1, 105, 10.1007/s11568-008-9017-x Gerling, 2013, Gene Expression Profiles of Peripheral Blood Mononuclear Cells Reveal Transcriptional Signatures as Novel Biomarkers for Cardiac Remodeling in Rats with Aldosteronism and Hypertensive Heart Disease, JACC Heart failure, 1, 469, 10.1016/j.jchf.2013.09.003